Evidence map›Paper›PMID 27698262›Full record

ArticleIntegrative cancer therapies2017

Boehmenan, a Lignan From the Chinese Medicinal Plant Clematis armandii, Inhibits A431 Cell Growth via Blocking p70S6/S6 Kinase Pathway.

Li-Long Pan, Xi-Ling Wang, Xiao-Ling Luo, Si-Yu Liu, Peng Xu, Jin-Feng Hu, Xin-Hua Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Integrative cancer therapies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Insights intoPharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. Nature-derived compounds modulating Wnt/Acta pharmaceutica Sinica. B · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Li-Long Pan1 Fudan University, Shanghai, China.
Xi-Ling Wang1 Fudan University, Shanghai, China.
Xiao-Ling Luo1 Fudan University, Shanghai, China.
Si-Yu Liu1 Fudan University, Shanghai, China.
Peng Xu1 Fudan University, Shanghai, China.
Jin-Feng Hu1 Fudan University, Shanghai, China.
Xin-Hua Liu1 Fudan University, Shanghai, China.
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, we have shown that boehmenan, a natural product isolated from the dried stem of Caulis clematidis armandii, exhibits various biological activities. The current study investigated the effects of boehmenan on the growth of human epidermoid carcinoma A431 cells. Cell viability and 50% inhibiting concentration (IC

Indexed as

ApoptosisCaspase 3Caspase 9Cell Cycle CheckpointsCell Line, TumorCell ProliferationCell SurvivalClematisHumansLignansMembrane Potential, MitochondrialMitochondriaPlants, MedicinalProto-Oncogene Proteins c-bcl-2Ribosomal Protein S6 Kinases, 70-kDaSignal TransductionboehmenanCaspase 3Caspase 9LignansProto-Oncogene Proteins c-bcl-2Ribosomal Protein S6 Kinases, 70-kDaA431boehmenancell cyclep70 ribosomal protein S6 kinaseproliferation

Identifiers

PMID27698262
PMCPMC5759931
OpenAlexW2529694888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.